Back to top

News

  /  Updates   /  News

  The Innovation in Breast Cancer Symposium, will be held in online format on February 17th and 18th, 2022. The two-day international scientific program aims to provide state-of-the-art information on breast cancer, achieving a balance of clinical, translational, and basic research, as well as providing a forum for interaction, communication, and interdisciplinary education for specialists with a special interest in breast cancer.     The registration period is now open. You can find all the information on the website through which you will have access to the registration section, general information, etc. Learn more: www.innovationinbreastcancer.com

  It is with great satisfaction that we invite you all to participate in the conference SNOLA 2022 – Translational research to current and future treatments, which will take place on February 11th and 12th, 2022, 100% online. This will be the largest and most complete Neuro Oncology event in Latin America. Snola was born and remains focused on making accessible the content of knowledge and integration of all areas involved in oncological treatments of the of the Central Nervous System, therefore, we are committed to delivering the best of the best to Latin American specialists, as we always seek to do. Our last biannual congress had more than 1000 participants, 201 brazilian speakers, 76 international speakears and 7 sponsor. This success was achieved despite all the difficulties that this multidisciplinary area faces in scientific and practical terms. The world pandemic scenario made us change our plans, and the conference that would take place in 2020 in Buenos Aires had to be postponed. In view of the new reality, we proposed to hold the congress 100% online with scientific programming focused on what is new in our field, themes and studies that have shownpromise for new protocols, new approaches to the already known ones, as well

Sign up for London Global Cancer Week 2021! Renowned international speakers will be discussing the impact of the Pandemic and the post-COVID-19 changes in the area of oncology in Latin America. The online event will take place on Friday, November 19th, 2 pm - 4 pm (GMT) - 10 am -12 am (BRT). Go to Zoom link

This report highlights immunotherapeutic standards in early-stage lung cancer. Moreover, strategies against sensitizing and resistance-mediating EGFR mutations as well as current perspectives regarding KRAS, MET, ROS1 and HER2 mutations are covered. Furthermore, immunotherapies and immunosupportive mechansims via e.g. anti-angiogenesis are addressed. Last but not least, this special issue includes a section about new vistas for patients with SCLC and expert interviews regarding resistance as one of the biggest challenges with targeted therapies. As an additional feature, you will find expert video interviews with Martin Reck, Luis Paz-Ares, David T. Cooke, Donald Harvey, and Ferdinandos Skoulidis on different conference highlights on our website. Download the full report

Brazilian researchers are asking for funding for a study that is close to identifying the best course of preoperative treatment for breast cancer and which will have benefits for women around the world. The Projeto Cura Institute has launched a campaign for donations from the public: "Together we can be stronger than Cancer", which is aiming to raise enough funds to enable data to be processed for one year as part of a completely Brazilian-based piece of research into the sequences for the treatment of HER2-negative type breast cancer. The NeoSamba study is a randomized clinical trial, which is now in phase 3. It is examining a new sequence of treatment including neoadjuvant chemotherapy (before breast surgery) and intends to monitor the treatment of almost 500 women over three years. During ASCO, the conference of the American Society of Clinical Oncology, in 2018, Dr. José Bines, the principal investigator for the study, talked about the conclusion of Phase II of NeoSamba. The research was conducted by the National Cancer Institute (INCA) and it investigated the cases of 118 patients to assess whether changing the order of the drugs in the anthracyclines and taxane classes (some of the most commonly-used drugs for chemotherapy) would

O IBC Lisbon 2021 trata-se um evento com um programa científico internacional, com a duração de dois dias e que visa fornecer informações de última geração sobre o câncer de mama, fomentando o equilíbrio entre a investigação clínica, translacional e básica, bem como, proporcionar um fórum de interação, discussão e aprendizagem para médicos e farmacêuticos hospitalares e outros especialistas (profissionais de saúde e investigadores) com especial interesse no câncer de mama. Data: de 14/10/2021 a 15/10/2021Local: OnlineEndereço: Lisboa, PortugalInvestimento/Taxa de Inscrição: 350€ (IVA incluído)Inscrições: http://www.innovationinbreastcancer.com/lisbon

Live Webinar, Saturday October 16th 10 renowned experts will discuss advances in the ESMO IN FOCUS LATAM 2021 Webinar and clinical challenges in Latin America. ESMO IN FOCUS is an Official ESMO program. The program will offer selected topics, including original presentations from the ESMO CONGRESS 2021. Renowned international speakers will select the most significant studies and comment on the main results with clinical impact. Relevant regional speakers will complement the presentation, demonstrating changes in clinical practice with updates to the treatment algorithm. Each section will feature a rich clinical discussion moderated by the program Chair and Co-Chair, complemented by questions from the participating audience. Register here to participate: https://www.esmoinfocuslatam2021.com Simultaneous translation: English/Spanish/Portuguese ESMO in Focus – Webinar LATAM 2021 is an officially licensed program of the European Society for Medical Oncology (ESMO), licensed exclusively by Springer Health do Brasil Ltda., sponsored by MSD in Latin America. © Copyright 2021 European Society for Medical Oncology. All rights reserved. This programme is made available in Latin America solely for educational and informational purposes and personal use only. Unauthorized reproduction is prohibited.

GU Review is in its 5th edition, and has become a long awaited event for oncologists. Annually, the scientific program is developed with the most actual in the treatment and diagnosis of genitourinary neoplasms. This year the congress will be broadcast online, and will present modules such as Kidney, Prostate, Penile and Bladder Cancer, bringing important national and international experts to discuss relevant topics in these areas. Subscribe now: https://rvmais.iweventos.com.br/gu-review2021

The International Congress of Oncological Gynecology is an event that is already part of the calendar of doctors and healthcare professionals. The congress is always carefully prepared to update and encourage constructive discussions for daily practice. The scientific program is designed to bring experienced professionals and authorities in gynecology oncology who can contribute with highly relevant and current topics. In this 9th edition, the highlights of the scientific program are: Endometrium Carcinoma, Uterus and Vulva Cancer, Pathology, Genetics and Ovarian Masses, Early Ovary Cancer and Advanced Ovary Cancer, as well as Discussion of Clinical Cases. Subscribe now: https://www.congressoginecologia.com.br/evento/gineco2021/home